Cefcube-T 1.125 Injection
Marketer
Veecube Healthcare Pvt Ltd
Salt Composition
Ceftriaxone (1000mg) + Tazobactum (125mg)
Overview Cefcube-T 1.125 Injection
Cefcube-T 1.125 Injection, a dual-action medication, combats diverse bacterial infections. Its mechanism halts microbial proliferation, thereby curbing infection spread. Administration must be strictly under a physician's guidance; adhere rigorously to the prescribed schedule. Complete the entire treatment course, regardless of symptom improvement; premature cessation may compromise efficacy. Potential side effects include nausea, vomiting, diarrhea, and dyspepsia; worsening effects necessitate immediate medical consultation. Seek immediate medical attention for allergic reactions (e.g., rashes, pruritus, edema, dyspnea). Prior to commencing treatment, inform your doctor of all current medications and pre-existing conditions. Pregnant or lactating individuals should consult their physician before use. Alcohol consumption should be avoided due to potential increased drowsiness. While generally not impairing driving ability, refrain from driving if drowsiness or dizziness occurs. Adequate rest, a nutritious diet, and ample hydration are crucial for optimal recovery. Your doctor may order blood tests and other diagnostic procedures to monitor treatment response.
Uses of Cefcube-T 1.125 Injection
Infections caused by bacteria
Major Benefits of Cefcube-T 1.125 Injection:
This medication will be administered by your healthcare provider. Self-medication is not permitted.
Common Side effects of Cefcube-T 1.125 Injection:
- Diarrhea
- Increased liver enzymes
- Allergic reaction
- Rash
How to use Cefcube-T 1.125 Injection:
This medication will be administered by your healthcare provider; self-medication is strictly prohibited.
How Cefcube-T 1.125 Injection works:
Ceftriaxone and Tazobactum, the components of Cefcube-T 1.125 Injection, act synergistically. Ceftriaxone, a cephalosporin antibiotic, disrupts bacterial cell wall synthesis, hindering bacterial survival. Tazobactum, a beta-lactamase inhibitor, counteracts bacterial resistance mechanisms, thereby boosting Ceftriaxone's effectiveness.
SAFETY ADVICE
AlcoholSAFE
Ingestion of alcohol alongside Cefcube-T 1.125 Injection presents no known adverse reactions.
PregnancySAFE IF PRESCRIBED
The injectable medication Cefcube-T 1.125 is typically deemed safe for pregnant individuals. Preclinical trials in animals revealed minimal or absent harm to the fetus; nevertheless, data from human studies are scarce.
Breast feedingCAUTION
The administration of Cefcube-T 1.125 Injection to breastfeeding mothers requires careful consideration. Lactation should be temporarily discontinued throughout the mother's course of treatment and until the medication is fully cleared from her system.
DrivingUNSAFE
Administering Cefcube-T 1.125 Injection could reduce attentiveness, impair vision, and induce drowsiness or dizziness. Driving should be avoided if such effects manifest.
KidneyCONSULT YOUR DOCTOR
Data regarding Cefcube-T 1.125 Injection's use in individuals with renal impairment is scarce. Physician consultation is advised.
LiverCAUTION
Administering Cefcube-T 1.125 Injection requires careful consideration in individuals with significant hepatic impairment; dosage modification may be necessary. Seek medical advice. Dosage alterations for Cefcube-T 1.125 Injection are not advised for those with less severe liver dysfunction.
What if you forget to take Cefcube-T 1.125 Injection :
Omit a Cefcube-T 1.125 Injection dose? Seek medical advice immediately.
Facts to Know About Cefcube-T 1.125 Injection
| Label | Value |
|---|---|
| Addictive | No. |
| Treatment Category | Antimicrobials |
3,018 People bought this recently